News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
Progenetics will distribute GeneStrat and Veristrat liquid biopsy tests in Israel, making Biodesix's tests available in the Middle East for the first time.
The new platform adds multiplexing capability to TearLab's current platform, which will help the firm develop clinical assays for eye and other diseases.
The company plans to use the proceeds to support research collaborations and to expand its commercial team.
The assay is designed to measure changes in blood levels of the peptide precursor procalcitonin to differentiate bacterial infections from viral ones.
The Swiss firm's assay combines a 29-gene host immune response panel with two tumor-derived proteins to detect early-stage colorectal cancer and large adenomatous polyps.
